UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
Eating out is a daily ritual for many families. This guide shows you how to choose credit card dining rewards that ac...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
The software sector is under pressure as AI-driven productivity bets collide with fears of cannibalization. ServiceNo...
SolarEdge leads a solar-stock surge, jumping about 14% as Canadian Solar adds strength. Investors cite AI infrastruct...
The iShares MSCI South Korea ETF has surged on AI memory demand, with Samsung Electronics and SK Hynix driving a hidd...
Tensions with Iran push costs beyond official tallies, raising inflation risk and weighing on markets. This report br...
A high-profile insider sale at Mineralys raises questions about what it might mean for the biotech's near-term trajec...
Two Harbors Investment Corp. shareholders approved an all-cash sale to CCM at $12 per share, ending a months-long bid...
Memory prices still skyrocketing have traders eyeing a new phase for Micron, SanDisk, and SK Hynix amid lingering sup...
Can a $5,000 investment unlock big potential in quantum computing stocks? This guide breaks down the landscape, insid...